#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Philadelphia positive chronic myeloid leukaemia Nasopharyngeal cancer Gastrooesophageal cancer Vascular calcification Mastocytosis Splenic marginal zone lymphoma Bulbospinal muscular atrophy congenital Systemic candida Autologous haematopoietic stem cell transplant Myeloproliferative neoplasm Canavan disease Deafness neurosensory Aicardi-Goutieres syndrome Follicular lymphoma stage II Arterial tortuosity syndrome More trials…

Learn about Rare Diseases

Toxic epidermal necrolysis – Trials in Disease Toxic epidermal necrolysis IgA nephropathy Paroxysmal nocturnal haemoglobinuria – Basic Information Idiopathic inflammatory myopathy – Life with Disease Mucous membrane pemphigoid – Trials in Disease IgA nephropathy – Life with Disease Rosai-Dorfman syndrome – Diagnostics Toxic epidermal necrolysis – Treatment Haemophilia A with anti factor VIII – Diagnostics More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Lacnotuzumab Glyceryl Trinitrate SOVATELTIDE Jk08 Emiplacel Sibeprenlimab Bintrafusp Alfa Capmatinib NADOFARAGENE FIRADENOVEC Crofelemer Benralizumab Ivabradine Obicetrapib Interleukin-1 Triamcinolone Hexacetonide Clobetasol Propionate Arsenic Trioxide Marstacimab Specific Nucleic Acid Sna-Xfsb GSKVX000000034794 More therapies…

Learn about Your Condition

Actinic cheilitis Aicardi-Goutieres syndrome Solitary fibrous tumour Scoliosis Menopausal symptoms Hepatic adenoma Dystonia Ependymoma Systemic sclerosis pulmonary Pancreaticoduodenectomy Psychogenic seizure Fallopian tube cancer stage IV Ewing's sarcoma Procedural headache Contusion More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe

🇦🇹 Austria

🇭🇷 Croatia

🇨🇿 Czech Republic

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇫🇷 France

🇩🇪 Germany

🇮🇸 Iceland

🇮🇹 Italy

🇱🇻 Latvia

🇱🇹 Lithuania

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇵🇹 Portugal

🇷🇴 Romania

🇸🇰 Slovakia

🇸🇮 Slovenia

🇪🇸 Spain

🇸🇪 Sweden

Myelodysplastic syndrome

Study Comparing CPX-351 and Conventional Drug Combination for Patients with High-Risk Myelodysplastic Syndromes and Oligoblastic Acute Myeloid Leukemia Before Stem Cell Transplant

Not recruiting

2 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
Study on the Effectiveness and Safety of Luspatercept for Patients with Lower-Risk Myelodysplastic Syndromes Requiring Red Blood Cell Transfusions

Not recruiting

3 1 1 1
Investigated Diseases:
- Bone marrow disorder
- Myelodysplastic syndrome
Investigated Drugs:
- Luspatercept
Study on the Safety and Effectiveness of Azacitidine and Venetoclax for Untreated Higher-Risk Myelodysplastic Syndromes Not Eligible for Transplant

Not recruiting

1 1 1
Investigated Drugs:
- Azacitidine
- Venetoclax

1 … 7 8 9

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Myelodysplastic syndrome

Study Comparing CPX-351 and Conventional Drug Combination for Patients with High-Risk Myelodysplastic Syndromes and Oligoblastic Acute Myeloid Leukemia Before Stem Cell Transplant

Study on the Effectiveness and Safety of Luspatercept for Patients with Lower-Risk Myelodysplastic Syndromes Requiring Red Blood Cell Transfusions

Study on the Safety and Effectiveness of Azacitidine and Venetoclax for Untreated Higher-Risk Myelodysplastic Syndromes Not Eligible for Transplant

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies